For professionals in the pharmaceutical industry, the reliable procurement of high-quality intermediates is fundamental to successful drug development and manufacturing. This article focuses on 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine, CAS 253168-94-4, a vital intermediate for the synthesis of Apremilast. Understanding the market dynamics and key considerations when sourcing this compound is crucial for procurement managers and R&D scientists alike.

As a leading manufacturer and supplier of pharmaceutical intermediates, we recognize the importance of transparency and quality. 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine, a white to off-white powder, is a key precursor that requires strict adherence to purity standards. When you look to buy this intermediate, consider its intended application: the enantioselective synthesis of Apremilast. This necessitates a high degree of purity to ensure the efficacy and safety of the final drug product.

The global market for pharmaceutical intermediates is competitive. However, prioritizing a supplier with a proven track record, robust quality control, and competitive price is essential. Companies often seek intermediates that offer excellent solubility and stability, facilitating easier handling and processing in their laboratories and production facilities. The chemical properties of CAS 253168-94-4 are well-documented, providing researchers with the necessary data for successful integration into synthesis routes.

For businesses aiming to secure a stable supply chain, identifying reliable manufacturers who can consistently deliver material meeting stringent specifications is paramount. Whether you are a small research lab or a large-scale pharmaceutical enterprise, the ability to purchase this intermediate in required quantities with assured quality is a significant advantage. We offer comprehensive support to help you navigate the sourcing process, providing competitive pricing and reliable logistics. Explore our offerings and discover why we are a preferred supplier for critical pharmaceutical intermediates.